DUNNE MICHAEL W. (Chief Scientific Officer) purchased 12.7% of their position (10K shares) of ITERUM THERAPEUTICS PLC on the open market
Open‑market purchase worth $18.4K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/19/2023ACC: 0001209191-23-059133
Officer· Chief Scientific Officer
Since Aug 2018
+10K
Net shares
Net buyer
$18.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+10K
Price / share
$1.84
Trade value
$18.44K
% of position
12.7%
12/18/2023
78.75K→88.75K
Total
Net shares
+10K
Net value
$18.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 12/18/2023 | P · Purchase | +10K | $1.84 | $18.44K | 12.7% | 78.75K | 88.75K |
| Total | +10K | $18.44K | ||||||
Derivative Transactions0
No derivative transactions reported